Status
From computational discovery to CRO synthesis and validation.
EvoPharma is transitioning from AI-guided design into outsourced experimental execution.
Computational discovery completedInitial target analysis, molecule design, and prioritization completed for early programs.
Lead molecules selectedCandidate molecules prioritized for synthesis and validation.
CRO synthesis initiatedExternal synthesis planning and CRO execution pathway established.
Validation strategy establishedExternal assays planned for biological activity, target engagement, mechanism, and early safety.
Global builder network expandingEvoPharma is seeking builders, not employees, to advance the company and earn ownership through impact.